Sun Pharmaceutical Industries Ltd. closed 14.30% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Sun Pharmaceutical Industries Ltd. closed 13.94% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Bajaj Finserv Ltd, and Sun ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

The NIFTY MIDCAP 150 index reflects the performance of mid-sized companies, providing investors with insights into this ...

Sun Pharma's clinical trial failure impacts SPARC stock, highlighting the challenges in derma-oncology research.

Sun Pharma disclosed that the drug did not meet primary endpoints in either study and as a result, the development of the SCD ...

Sun Pharma’s experimental drug SCD-044 did not meet its main goals in Phase 2 trials for psoriasis and atopic dermatitis. The ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

CHENNAI: Shares of India's largest drug maker Sun Pharmaceutical Industries fell almost 1% on main stock exchanges on ...